Previous Article | Next Article 
Journal of Clinical Microbiology, December 2008, p. 4104-4105, Vol. 46, No. 12
0095-1137/08/$08.00+0 doi:10.1128/JCM.01288-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Hepatitis and Human Bocavirus Primary Infection in a Child with T-Cell Deficiency
Leena Kainulainen,1*
Matti Waris,2
Maria Söderlund-Venermo,3
Tobias Allander,4
Klaus Hedman,5 and
Olli Ruuskanen1
Department of Pediatrics, Turku University Hospital, Box 52, 20521 Turku, Finland,1
Department of Virology, University of Turku, Kiinamyllynkatu 13, 20520 Turku, Finland,2
Department of Virology, Haartman Institute, Box 21, 00014 University of Helsinki, Helsinki, Finland,3
Department of Clinical Microbiology, Karolinska University Hospital, SE-17176 Stockholm, Sweden,4
Department of Virology, Haartman Institute, Box 21, 00014 University of Helsinki and Helsinki University Hospital, Helsinki, Finland5
Received 8 July 2008/
Returned for modification 15 August 2008/
Accepted 28 September 2008

ABSTRACT
Human bocavirus (HBoV) is one of the recently identified respiratory
viruses. The clinical features of HBoV infection have not yet
been fully elucidated. We report an invasive HBoV infection
and hepatitis in a boy with cartilage-hair hypoplasia and severe
T-cell immunodeficiency.

CASE REPORT
Cartilage-hair hypoplasia and a homozygous A70G mutation were
diagnosed in a boy at the age of 2 months. A severe immunodeficiency
was found at the age of 3 months. The boy was lymphopenic (1.8
x 10
9/liter) and showed a marked reduction in CD3
+ T cells (22%;
0.400
x 10
9/liter; normal range, 2.2
x 10
9 to 6.5
x 10
9/liter).
The T-cell function was severely impaired, as shown by low lymphocyte
proliferation responses (10% of control responses) to phytohemagglutinin,
concanavalin A, and pokeweed mitogens. Immunoglobulin M (IgM)
and IgG antibody formations in vitro measured by an enzyme-linked
immunospot assay were normal. Upon receiving a pertussis-diphtheria-tetanus
vaccination, the patient showed good antibody responses against
tetanus and diphtheria. At the age of 4 months, rhinovirus was
detected by PCR in nasopharyngeal aspirate (NPA) and remained
detectable for 2 weeks. At 5 months, the patient was hospitalized
for rotavirus gastroenteritis, with antigen in feces shown for
5 days. At the age of 6 months, palivizumab prophylaxis for
respiratory syncytial virus was given for 3 months because of
an ongoing epidemic. At 7 months of age, on 9 March 2008, the
boy was admitted to the hospital because of fever, skin blisters,
and a painful perianal ulceration. He had no respiratory symptoms.
At the time of admission, his white blood cell count was 13.0
x 10
9/liter and his serum C-reactive protein level was 31 mg/liter.
Intravenous cloxacillin, ceftazidime, and acyclovir were started.
Blood culture results remained negative. The chest X ray done
at admission was unremarkable. Herpes simplex cultures as well
as PCR tests for adenovirus, human herpesvirus 6, parvovirus,
cytomegalovirus, and enteroviruses of the blister fluid and
perianal ulceration were negative. Serum IgM antibodies for
Epstein-Barr virus remained undetectable. Hepatomegaly was observed.
Serum alanine aminotransferase and gamma-glutamyltransferase
levels were elevated: 474 U/liter and 178 U/liter, respectively.
Serum prealbumin was low (0.08 g/liter), confirming liver dysfunction.
The patient received a single dose (800 mg/kg of body weight)
of intravenous immunoglobulin (IVIG) on 14 March 2008. Amphotericin
B was added to the treatment. After 10 days of illness, liver
function normalized and the patient was discharged. At the time
of hepatitis, human bocavirus (HBoV) was detected in consecutive
NPA, feces, urine, and serum samples. The highest copy numbers
were found in NPA and feces. For serological diagnosis, an IgG
enzyme immunoassay (EIA) and IgM mu capture EIA were used, with
recombinant virus-like particles applied as an antigen (M. Söderlund-Venermo,
unpublished data). Significant rises in serum IgM and IgG HBoV
antibodies were demonstrable, confirming acute infection.
After 1 month, the PCR was negative with NPA, feces, urine, and serum samples but again turned positive after 4 weeks with NPA and feces samples with low copy numbers. At the same time, the patient had skin blisters but was otherwise well. A skin biopsy was taken of a blister, and it was negative for parvovirus and for HBoV by PCR. Before the onset of hepatitis, we searched for HBoV by PCR in preceding NPA and serum samples, with negative results (Table 1) . Two months after the onset of HBoV infection, the patient's immunological status showed transient recovery. The lymphocyte proliferation response to phytohemagglutinin increased from 1,538 cpm to 8,950 cpm but deteriorated again at the same time that HBoV PCR results returned positive.
View this table:
[in this window]
[in a new window]
|
TABLE 1. HBoV PCR results for various samples and levels of serum HBoV antibodies in a patient with cartilage-hair hypoplasiaa
|
HBoV is one of the recently identified respiratory viruses.
The prevalence of HBoV in respiratory specimens from young children
with acute respiratory illnesses has ranged from 2% to 19%.
HBoV is commonly detected in association with other respiratory
viruses, raising the question of whether it is a passenger or
a genuine respiratory pathogen (
2,
4,
9). Acute expiratory wheezing
and pneumonia are the clinical features typically associated
with HBoV (
1,
3,
4,
9). When it is a sole viral finding in the
respiratory tract, HBoV usually occurs in high DNA levels and
is often accompanied by the detection of HBoV DNA in serum as
well as the appearance of specific IgM and IgG antibodies (
1,
5).
HBoV is a ubiquitous virus. However, the clinical features of HBoV infection have not yet been fully elucidated, especially for immunosuppressed subjects (4, 9). Schenk and coworkers (8) reported disseminated (NPA, serum, and feces) HBoV infection in a child after stem cell transplantation. Fecal shedding of HBoV continued for 2 months. We have earlier reported a child with acute lymphoblastic leukemia who was NPA positive for HBoV for 3 months in five consecutive febrile episodes (6). Kupfer et al. described an adult patient with malignant B-cell lymphoma and a severe infection with long-lasting fever and pneumonia, in whom HBoV was the sole pathogen found in NPA (7). We describe a hereditably immunodeficient child with disseminated HBoV infection with clinical hepatitis and skin manifestations but without respiratory symptoms and without other concomitant viruses. A high HBoV DNA load in NPA, viremia, detection of IgM in serum, and a diagnostic elevation of IgG in paired serum samples confirmed acute primary HBoV infection. The administrated IVIG probably affected HBoV IgG levels. However, IVIG contains only IgG and does not confound IgM responses. In addition, IVIG has a half-life of 28 days. The cause of hepatitis was not specifically identified because no liver biopsies were done. However, our observations strongly suggest that HBoV was the causative agent. Recent studies in Denmark have shown that 70% of infants shed HBoV for less than a month and 26% for 2 months (10). In our patient, the virus turned transitorily negative but appeared positive on 6 June 2008 in NPA and feces about 3 months after the onset of infection, suggesting chronic HBoV infection in a child with T-cell deficiency. The true HBoV pathogenesis is not yet fully understood, and perhaps the results seen here show a more exaggerated form of the normal infection in an immunocompromised patient.

ACKNOWLEDGMENTS
This study was supported by the Academy of Finland (grant 1122539),
the Sigrid Jusélius Foundation, and the Helsinki University
Central Hospital Research and Education Fund.

FOOTNOTES
* Corresponding author. Mailing address: Department of Pediatrics, Turku University Hospital, Box 52, 20521 Turku, Finland. Phone: 358-2-3130000. Fax: 358-2-3131460. E-mail:
leena.kainulainen{at}tyks.fi 
Published ahead of print on 8 October 2008. 

REFERENCES
1 - Allander, T., T. Jartti, S. Gupta, H. G. Niesters, P. Lehtinen, R. Österback, T. Vuorinen, M. Waris, A. Bjerkner, A. Tivel-ljung, B. G. van den Hoogen, T. Hyypiä, and O. Ruuskanen. 2007. Human bocavirus and acute wheezing in children. Clin. Infect. Dis. 44:904-910.[CrossRef][Medline]
2 - Allander, T., M. T. Tammi, M. Eriksson, A. Bjerker, A. Tivelljung-Lindell, and B. Andersson. 2005. Cloning of a human parvovirus by molecular screening of respiratory samples. Proc. Natl. Acad. Sci. USA 102:12891-12896.[Abstract/Free Full Text]
3 - Bastien, N., K. Brandt, K. Dust, D. Ward, and Y. Li. 2006. Human bocavirus infection. Emerg. Infect. Dis. 12:848-850.[Medline]
4 - Kahn, J. 2008. Human bocavirus: clinical significance and implications. Curr. Opin. Pediatr. 20:62-66.[CrossRef][Medline]
5 - Kantola, K., L. Hedman, T. Allander, T. Jartti, P. Lehtinen, O. Ruuskanen, K. Hedman, and M. Söderlund-Venermo. 2008. Serodiagnosis of human bocavirus infection. Clin. Infect. Dis. 46:540-546.[CrossRef][Medline]
6 - Koskenvuo, M., M. Möttönen, M. Waris, T. Allander, T. Salmi, and O. Ruuskanen. 2007. Human bocavirus in children with acute lymphoplastic leukemia. Eur. J. Pediatr. Epub 2007 Nov. 24.
7 - Kupfer, B., J. Vehreschild, O. Cornely, R. Kaiser, G. Plum, C. Viazov, C. Franzen, A. Simon, A. Müller, and O. Shildgen. 2006. Severe pneumonia and human bocavirus in an adult. Emerg. Infect. Dis. 12:1614-1616.[Medline]
8 - Schenk, T., B. Strahm, U. Kontny, M. Hufnagel, D. Neuman-Haefelin, and V. Falcone. 2007. Disseminated bocavirus infection after stem cell transplant. Emerg. Infect. Dis. 13:1425-1427.[Medline]
9 - Schildgen, O., A. Müller, T. Allander, I. M. Mackay, S. Völz, B. Kupfer, and A. Simon. 2008. Human bocavirus: passenger or pathogen in acute respiratory tract infections? Clin. Microbiol. Rev. 21:291-304.[Abstract/Free Full Text]
10 - von Linstow, M. L., M. Hogh, and B. Hogh. 2008. Clinical and epidemiological characteristics of human bocavirus in Danish infants—results from a prospective birth cohort study, abstr. 58. Abstr. 26th Annu. Meet. Eur. Soc. Paediatr. Infect. Dis.—ESPID, Gratz, Austria.
Journal of Clinical Microbiology, December 2008, p. 4104-4105, Vol. 46, No. 12
0095-1137/08/$08.00+0 doi:10.1128/JCM.01288-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
de Vries, J. J. C., Bredius, R. G. M., van Rheenen, P. F., Smiers, F. J. W., Scholvinck, E. H., Vossen, A. C. T. M., Claas, E. C. J., Niesters, H. G. M.
(2009). Human Bocavirus in an Immunocompromised Child Presenting with Severe Diarrhea. J. Clin. Microbiol.
47: 1241-1243
[Abstract]
[Full Text]